Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Duet

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivoM Duet, C Ajzenberg, S Benelhadj, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 19, 2013
Malignant head/neck paragangliomas. Comparative studyA Mediouni, S Ammari, M Wassef, et al.
Acta Endocrinologica|September 1, 1987
The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegalyJ Timsit, P Chanson, E Larger, et al.
Clinical Endocrinology|January 13, 1998
Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotideF Broson-Chazot, C Houzard, C Ajzenberg, et al.
Neuro-Chirurgie|May 27, 2014
[Chordoma]B George, D Bresson, S Bouazza, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivoM Duet, C Ajzenberg, S Benelhadj, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 19, 2013
Malignant head/neck paragangliomas. Comparative studyA Mediouni, S Ammari, M Wassef, et al.
Acta Endocrinologica|September 1, 1987
The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegalyJ Timsit, P Chanson, E Larger, et al.
Clinical Endocrinology|January 13, 1998
Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotideF Broson-Chazot, C Houzard, C Ajzenberg, et al.
Neuro-Chirurgie|May 27, 2014
[Chordoma]B George, D Bresson, S Bouazza, et al.
Pageof 3